Tribe Says PTAB Can't Weigh Restasis Patents During Appeal
The Native American tribe that acquired patents covering Allergan PLC's Restasis medication told the Patent Trial and Appeal Board on Thursday that the tribe's recent appeal to the Federal Circuit prevents...To view the full article, register now.
Already a subscriber? Click here to view full article